Member of the Law Society of British Columbia
Dr. Ming-Lum completed his doctorate in the Faculty of Medicine at the University of British Columbia, where his research focused on defining immunoregulatory signal transduction pathways and characterizing the mechanism of action of novel small molecule compounds for the treatment of inflammatory diseases and cancers. He has authored numerous peer-reviewed articles and presented his research at international conferences.
Dr. Ming-Lum also worked for several years in the pre-clinical pharmacology department of a Vancouver-based company developing therapies for the treatment of ocular diseases, inflammatory diseases, and cancer.